Recent Updates
Recently added Catalysts
HROW Positive Sentiment

Harrow to Present at William Blair’s 46th Annual Growth Stock Conference

Key Takeaway: Harrow (Nasdaq: HROW) will present at William Blair's 46th Annual Growth Stock Conference on June 3, 2026, at 8:40 AM CT in Chicago. The presentation will be available via live webcast on the company's website, with a replay accessible for 90 days. Harrow specializes in ophthalmic disease management solutions.
Price reaction · baseline $34.17 (2026-05-26 close) · hit after-hours · clean, no other HROW news in the window
day 0 close
+0.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Harrow is actively engaging with investors at a prominent conference.
  • The company showcases its commitment to ophthalmic disease management.
  • The live webcast allows broader access to the presentation.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+67%
120-day peak, hindsight
Typical move
11.8%
average across 4 past catalysts
Cash runway
~25 mo
Minimal dilution risk
Lead asset
MELT-100
Phase 1 · Healthy Volunteers

Full Press Release Details

NASHVILLE, Tenn., May 27, 2026 (GLOBE NEWSWIRE) -- Harrow (Nasdaq: HROW), a leading provider of ophthalmic disease management solutions in North America, today announced that management will present at William Blair’s 46thAnnual Growth Stock Conference on Wednesday, June 3, 2026, at 8:40 AM CT, in Chicago, IL.
The presentation will bewebcast liveand can be found on the Company’s website. A replay will be on the website for approximately 90 days following the event.
About HarrowHarrow, Inc. (Nasdaq: HROW) is a leading provider of ophthalmic disease management solutions in North America, offering a comprehensive portfolio of products that address conditions affecting both the front and back of the eye, such as dry eye disease, wet (or neovascular) age-related macular degeneration, cataracts, refractive errors, glaucoma and a range of other ocular surface conditions and retina diseases. Harrow was founded with a commitment to deliver safe, effective, accessible, and affordable medications that enhance patient compliance and improve clinical outcomes. For more information about Harrow, please visitharrow.comand connect with us onLinkedIn.

Contact:Mike Biega, Vice President of Investor Relations and Communicationsmbiega@harrowinc.com617-913-8890

Frequently Asked Questions

When will Harrow present at the conference?

Harrow will present on June 3, 2026, at 8:40 AM CT.

Where is the conference being held?

The conference will take place in Chicago, IL.

How can I access the presentation?

The presentation will be webcast live on Harrow's website.

Will there be a replay of the presentation?

Yes, a replay will be available for approximately 90 days.

Last updated: May 27, 2026